Sawyer & Company, Inc Abbott Laboratories Transaction History

Sawyer & Company, Inc

$252 Million
Q2 2024

A detailed history of Sawyer & Company, Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Sawyer & Company, Inc holds 24,548 shares of ABT stock, worth $2.8 Million. This represents 1.01% of its overall portfolio holdings.

Number of Shares

24,548

Previous 24,703 0.63%

Holding current value

$2.8 Million

Previous $2.81 Million 9.12%

% of portfolio

1.01%

Previous 1.13%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	SELL	$100.73 - $112.44 $15,613 - $17,428	-155 Reduced 0.63%	24,548 $2.55 Million
Q1 2024 Apr 16, 2024	SELL	$109.52 - $120.96 $39,427 - $43,545	-360 Reduced 1.44%	24,703 $2.81 Million
Q4 2023 Jan 17, 2024	SELL	$90.19 - $110.4 $97,315 - $119,121	-1,079 Reduced 4.13%	25,063 $2.76 Million
Q3 2023 Oct 25, 2023	SELL	$95.53 - $114.62 $9,075 - $10,888	-95 Reduced 0.36%	26,142 $2.53 Million
Q1 2023 Apr 19, 2023	SELL	$96.86 - $114.01 $22,665 - $26,678	-234 Reduced 0.88%	26,237 $2.72 Million
Q4 2022 Jan 11, 2023	BUY	$95.06 - $111.52 $51,332 - $60,220	540 Added 2.08%	26,471 $2.91 Million
Q3 2022 Oct 25, 2022	BUY	$96.76 - $112.03 $2,515 - $2,912	26 Added 0.1%	25,931 $2.51 Million
Q1 2022 Apr 26, 2022	SELL	$114.02 - $139.04 $4,902 - $5,978	-43 Reduced 0.17%	25,905 $3.07 Million
Q4 2021 Jan 14, 2022	SELL	$115.53 - $141.46 $12,246 - $14,994	-106 Reduced 0.41%	25,948 $3.65 Million
Q3 2021 Nov 03, 2021	BUY	$116.66 - $129.06 $37,914 - $41,944	325 Added 1.26%	26,054 $3.08 Million
Q2 2021 Jul 29, 2021	BUY	$105.79 - $124.53 $29,621 - $34,868	280 Added 1.1%	25,729 $2.98 Million
Q1 2021 Apr 22, 2021	SELL	$108.84 - $128.23 $43,536 - $51,291	-400 Reduced 1.55%	25,449 $3.05 Million
Q4 2020 Jan 26, 2021	SELL	$105.0 - $114.42 $21,000 - $22,884	-200 Reduced 0.77%	25,849 $2.83 Million
Q3 2020 Oct 20, 2020	SELL	$91.64 - $111.29 $59,199 - $71,893	-646 Reduced 2.42%	26,049 $2.84 Million
Q2 2020 Jul 31, 2020	SELL	$76.57 - $98.0 $22,588 - $28,910	-295 Reduced 1.09%	26,695 $2.44 Million
Q1 2020 May 06, 2020	SELL	$62.82 - $91.86 $27,012 - $39,499	-430 Reduced 1.57%	26,990 $2.13 Million
Q4 2019 Jan 13, 2020	BUY	$78.51 - $87.4 $28,263 - $31,464	360 Added 1.33%	27,420 $2.38 Million
Q3 2019 Oct 17, 2019	SELL	$81.84 - $88.74 $70,791 - $76,760	-865 Reduced 3.1%	27,060 $2.26 Million
Q2 2019 Jul 23, 2019	SELL	$72.88 - $85.0 $72,880 - $85,000	-1,000 Reduced 3.46%	27,925 $2.35 Million
Q1 2019 May 06, 2019	SELL	$66.22 - $80.06 $9,933 - $12,009	-150 Reduced 0.52%	28,925 $2.31 Million
Q4 2018 Jan 25, 2019	SELL	$65.56 - $74.27 $65,232 - $73,898	-995 Reduced 3.31%	29,075 $2.1 Million
Q3 2018 Oct 22, 2018	SELL	$60.81 - $73.36 $9,425 - $11,370	-155 Reduced 0.51%	30,070 $2.21 Million
Q4 2017 Jan 11, 2018	BUY	$53.68 - $57.47 $1.62 Million - $1.74 Million	30,225	30,225 $1.73 Million

Others Institutions Holding ABT

# of Institutions

3,131

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $199B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sawyer & Company, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sawyer & Company, Inc with notifications on news.

Account

Sawyer & Company, Inc Abbott Laboratories Transaction History